MSI-H/ MMRd
Who we are
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors
An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
GCC19CART for Patients With Metastatic Colorectal Cancer
Sotorasib and Panitumumab Versus Investigator’s Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation (CodeBreak 300)
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
Assessing the Immunogenicity of pING-hHER3FL
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
